Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders.

MLA

Dooms, M., et al. “Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders.” Frontiers in Pharmacology, vol. 13, May 2022, pp. 1–12. EBSCOhost, https://doi.org/10.3389/fphar.2022.775217.

APA

Dooms, M., Saesen, R., Steemans, I., Lansens, J., & Huys, I. (2022). Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders. Frontiers in Pharmacology, 13, 1–12. https://doi.org/10.3389/fphar.2022.775217

Chicago

Dooms, M, R Saesen, I Steemans, J Lansens, and I Huys. 2022. “Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders.” Frontiers in Pharmacology 13 (May): 1–12. doi:10.3389/fphar.2022.775217.